Market Place
Sourcing Support
Senti Biosciences Educational Session at AACR Annual Meeting 2026
13 Apr 2026 //
GLOBENEWSWIRE
Senti Bio Publishes Logic-Gated CAR Design in Cell Systems
01 Apr 2026 //
GLOBENEWSWIRE
Senti Bio Reports 2025 Financial Results And Corporate Update
27 Mar 2026 //
GLOBENEWSWIRE
Senti Biosciences Presents SENTI-202 Data at Innate Killer Summit
23 Mar 2026 //
GLOBENEWSWIRE
Senti Bio To Present At Leerink Partners Global Healthcare
03 Mar 2026 //
GLOBENEWSWIRE
Senti Bio To Present At TD Cowen Health Care Conference
24 Feb 2026 //
GLOBENEWSWIRE
Senti Bio Wraps Ph 1 Trial Enrollment For SENTI-202 In (R/R AML)
11 Feb 2026 //
GLOBENEWSWIRE
Senti Bio Joins Investor CEO Connect To Present AML Data At ASH
14 Jan 2026 //
GLOBENEWSWIRE
Senti Bio Joins Panel At Biotech Showcase During J.P. Morgan Conf
09 Jan 2026 //
GLOBENEWSWIRE
Senti Biosciences Announces New Employment Inducement Grants
18 Dec 2025 //
GLOBENEWSWIRE
Senti Bio Secures FDA RMAT for SENTI-202 in R/R AML
09 Dec 2025 //
GLOBENEWSWIRE
Senti Bio Announces SENTI-202`s MRD-Negative AML Remissions
09 Dec 2025 //
GLOBENEWSWIRE
Senti Bio To Discuss SENTI-202 Clinical Data At ASH Meeting 2025
04 Dec 2025 //
GLOBENEWSWIRE
Senti Bio Confirms Phase 1 SENTI-202 (AML) Data Readout at ASH
13 Nov 2025 //
GLOBENEWSWIRE
Senti Bio To Unveil SENTI-202, Clinical Data at ASH 2025
03 Nov 2025 //
GLOBENEWSWIRE
Senti Bio To Present At Chardan`s Genetic Medicines Conference
16 Oct 2025 //
GLOBENEWSWIRE
Senti Bio To Present At Biojapan
06 Oct 2025 //
GLOBENEWSWIRE
Senti Bio at MedInvest Biotech & Pharma Conference
18 Sep 2025 //
GLOBENEWSWIRE
Senti Bio to Present at H.C. Wainwright Global Conference
02 Sep 2025 //
GLOBENEWSWIRE
Senti Biosciences to present at Webull Financial webinar
14 Aug 2025 //
GLOBENEWSWIRE
Senti Bio Discusses Ph 2 Dose Selection for SENTI-202 in Leukemia
12 Aug 2025 //
GLOBENEWSWIRE
Senti Bio Reports Q2, Ph 1 SENTI-202 AML Data Due Q4 2025
07 Aug 2025 //
GLOBENEWSWIRE
Senti Bio Sets Ph 2 Dose in Ph 1 Study of Senti-202 in AML
05 Aug 2025 //
GLOBENEWSWIRE
Senti Bio`s CMO, Kanya Rajangam, to Present at BioScience Forum
21 Jul 2025 //
GLOBENEWSWIRE
Senti Bio Names Bryan Baum Entrepreneurial Leader and Investor
18 Jul 2025 //
GLOBENEWSWIRE
Senti Bio Participates in Nasdaq Amplify Spotlight Series
30 Jun 2025 //
GLOBENEWSWIRE
Senti Bio to Present at 2025 SEED Conference
24 Jun 2025 //
GLOBENEWSWIRE
Senti Biosciences Announces New Employment Inducement Grants
09 Jun 2025 //
GLOBENEWSWIRE
Senti Bio to Join Virtual Chat by Chardan Capital Markets, LLC
06 Jun 2025 //
GLOBENEWSWIRE
Senti Bio Gets $1M CIRM Grant For SENTI-202 Clinical Program
22 May 2025 //
GLOBENEWSWIRE
Senti Bio to Present at Webull Corporate Connect Biotech Webinar
22 May 2025 //
GLOBENEWSWIRE
Senti Bio Releases Mechanism of Action Video for SENTI-202
08 May 2025 //
GLOBENEWSWIRE
Senti Bio Reports Q1 2025 Results and Positive SENTI-202 Update
06 May 2025 //
GLOBENEWSWIRE
Senti Bio Releases Virtual Investor What This Means Segment
01 May 2025 //
GLOBENEWSWIRE
Senti Bio to Present at the Citizens JMP Life Sciences Conference
30 Apr 2025 //
GLOBENEWSWIRE
Senti Bio`s SENTI-202 Shows Positive Results in AML Treatment
28 Apr 2025 //
GLOBENEWSWIRE
Senti Bio to Discuss SENTI-202 Clinical Data at AACR Meeting
24 Apr 2025 //
GLOBENEWSWIRE
Senti Bio Joins Live Virtual Investor Closing Bell Segment
16 Apr 2025 //
GLOBENEWSWIRE
Senti Bio Adds James B. Trager, Ph.D. to Advisory Board
10 Apr 2025 //
GLOBENEWSWIRE
Senti Bio Joins Webull Corporate Connect Service Platform
07 Apr 2025 //
GLOBENEWSWIRE
Senti Bio to Present SENTI-202 Clinical Data at AACR Meeting 2025
03 Apr 2025 //
GLOBENEWSWIRE
Senti Bio Appoints Feng Hsiung to Board of Directors
13 Mar 2025 //
GLOBENEWSWIRE
Senti Bio Strengthens Leadership Team with Strategic Hires
25 Feb 2025 //
GLOBENEWSWIRE
Senti Bio Announces Additional $11.5 Million of Financing
06 Jan 2025 //
GLOBENEWSWIRE
Senti Biosciences Announces New Employment Inducement Grants
03 Dec 2024 //
GLOBENEWSWIRE
Senti Bio Announces Q3 2024 Results & Recent Pipeline & Highlights
14 Nov 2024 //
GLOBENEWSWIRE
Senti Bio to Participate in Upcoming Investor Conferences
03 Sep 2024 //
GLOBENEWSWIRE
Senti Bio Announces Q2 2024 Results And Pipeline Highlights
13 Aug 2024 //
GLOBENEWSWIRE
Senti Bio Executes CIRM Grant For SENTI-202 Clinical Development
05 Aug 2024 //
GLOBENEWSWIRE
Senti Bio Receives CIRM Grant For CAR-NK Cell Therapy Development
01 Jul 2024 //
GLOBENEWSWIRE
Senti Bio Doses First Patient In SENTI-202 Trial For Hematologic Malignancies
13 May 2024 //
GLOBENEWSWIRE
Senti Bio: Data Shows CAR-NK Potential For AML In SENTI-202 Preclinical
30 Apr 2024 //
GLOBENEWSWIRE
Senti Bio Announces FDA Clearance of IND Application for SENTI-202
22 Dec 2023 //
GLOBENEWSWIRE
Senti Bio Highlights Preclinical Data Cell Therapy AACR Meeting
17 Apr 2023 //
GLOBENEWSWIRE
Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Therapies
27 Jan 2023 //
GLOBENEWSWIRE
